Brief Research Report

Published on 22 Nov 2024

Superior survival benefits of triple combination immunotherapy compared to standard chemotherapy as second-line treatment for advanced biliary tract cancer: a retrospective analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Peipei Shang
Heming Xu
Tianmei Zeng
Cheng Lou
Wei Wei
Guang Yang
Zhuo Cheng
Xiaowen Cui
Weipeng Hong
Weidong Shen

Frontiers in Oncology

doi 10.3389/fonc.2024.1482909

Case Report

Published on 21 Nov 2024

Imaging findings of primary hepatic leiomyosarcoma: a case report and literature review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lifen Yan
Runqian Huang
Shuting Chen
Jiawei Chen
Jinglei Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1490717

108 views

Original Research

Accepted on 20 Nov 2024

Cost-Effectiveness of Camrelizumab Plus Rivoceranib for Advanced Hepatocellular Carcinoma in the Context of Regional Disparities in China

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zhonghua Zhao
Xiongying Jiang
Shiping Wen
Yanzhang Hao

Frontiers in Oncology

doi 10.3389/fonc.2024.1491404

104 views

Case Report

Accepted on 20 Nov 2024

Combination Therapy for Hepatocellular Carcinoma with Inferior Vena Cava or Right Atrial Tumor Thrombus in the Era of Combined Targeted and Immunotherapeutic Agents

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yubin Hai
Tingting Lin
Guangyi Wang
Xiaodong Sun
Lan Wang
yuying hai
Saisai Chen
Xiaoju Shi

Frontiers in Oncology

doi 10.3389/fonc.2024.1470374

Case Report

Published on 20 Nov 2024

The survival and safety of metastatic hepatocellular carcinoma treated with lenalidomide as second-line therapy: a case report and review of the literature

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tao Li
Ying Zhao
Keren Li
Gong Li
Guangxin Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1461936

211 views

Case Report

Accepted on 19 Nov 2024

A rare case of intragastric Metastasis After Liver Transplantation for Liver Cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Youfeng Xue
Baojie Shi
Jianfa Zhong
Guimei Wang
Jie Wang
Wenbin An
Yunyun Qian
Zhaojie Su
Zhihai Peng
Hao Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1495517

Systematic Review

Published on 19 Nov 2024

Robotic versus laparoscopic pancreaticoduodenectomy for pancreatic and periampullary tumors: a meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Gang Tang
Fang Chen
Rui Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1486504

185 views

Original Research

Accepted on 18 Nov 2024

Adjuvant sorafenib for hepatocellular carcinoma after radiofrequency ablation versus radiofrequency ablation: analysis of its efficacy and safety Author Information

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Junxiao Wang
Rui Liu
Zhenyu Wen
Zejie Sang
Xiang Yang
Mingchao Ding
Hui Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1383312

Review

Published on 15 Nov 2024

Progress and perspectives on BMP9-ID1 activation of HIF-1α and VEGFA to promote angiogenesis in hepatic alveolar echinococcosis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Fei Ke
Meng-Zhao Xu
Long Ma
Qi-Dong Chen
Bei-Bei He
Ji-De A

Frontiers in Oncology

doi 10.3389/fonc.2024.1480683

201 views

Original Research

Published on 14 Nov 2024

The assessment of postoperative cholangitis in malignant biliary obstruction: a real-world study of nasobiliary drainage after endoscopic placement of self-expandable metal stent

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hengwei Jin
Chang Fu
Xu Sun
Changqing Fan
Junhong Chen
Hao Zhou
Kai Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1440131

203 views

Clinical Trial

Published on 14 Nov 2024

Rhus verniciflua stokes extract, a traditional herbal medicine, combined with first-line chemotherapy for unresectable locally advanced and metastatic pancreatic cancer: a prospective observational pilot study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hayun Jin
Su Hyeon Lee
Eun Hye Kim
Su Bin Park
Namyoung Park
Kwang Ro Joo
Seong Woo Yoon

Frontiers in Oncology

doi 10.3389/fonc.2024.1469616

254 views

Original Research

Accepted on 13 Nov 2024

Prolonged survival by combination treatment of a standardized herbal extract from Japanese Kampo-Medicine (Juzentaihoto) and Gemcitabine in an orthotopic transplantation pancreatic cancer model

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Joanna Napp
Paulina Siebel
Hans Rausch
Kenny Kuchta
Thomas Efferth
Frauke Alves
Volker Ellenrieder
Silke Cameron

Frontiers in Oncology

doi 10.3389/fonc.2024.1454291

Original Research

Accepted on 13 Nov 2024

Sorafenib Combined with Tarexib for First-Line Treatment of Unresectable Hepatocellular Carcinoma and Its Predictive Role and Correlation with PD-L1 CTCs

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lin Xu
Xu Che

Frontiers in Oncology

doi 10.3389/fonc.2024.1478596

Original Research

Published on 08 Nov 2024

Unveiling Tim-3 immune checkpoint expression in hepatocellular carcinoma through abdominal contrast-enhanced CT habitat radiomics

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zhishen Tang
Wei Wang
Bo Gao
Xuyang Liu
Xiangyu Liu
Yingquan Zhuo
Jun Du
Fujun Ai
Xianwu Yang
Huajian Gu

Frontiers in Oncology

doi 10.3389/fonc.2024.1456748

274 views

Original Research

Published on 08 Nov 2024

Deep learning radiomics based on contrast enhanced MRI for preoperatively predicting early recurrence in hepatocellular carcinoma after curative resection

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ying Zhao
Sen Wang
Yue Wang
Jun Li
Jinghong Liu
Yuhui Liu
Haitong Ji
Wenhan Su
Qinhe Zhang
Qingwei Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1446386

205 views

Mini Review

Published on 07 Nov 2024

Emerging horizons on molecular and circulating biomarkers in pancreatic adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Marta Moretti
Antonella Farina
Antonio Angeloni
Emanuela Anastasi

Frontiers in Oncology

doi 10.3389/fonc.2024.1483306

294 views

Navigation group

Articles

Superior survival benefits of triple combination immunotherapy compared to standard chemotherapy as second-line treatment for advanced biliary tract cancer: a retrospective analysis

Imaging findings of primary hepatic leiomyosarcoma: a case report and literature review

Cost-Effectiveness of Camrelizumab Plus Rivoceranib for Advanced Hepatocellular Carcinoma in the Context of Regional Disparities in China

Combination Therapy for Hepatocellular Carcinoma with Inferior Vena Cava or Right Atrial Tumor Thrombus in the Era of Combined Targeted and Immunotherapeutic Agents

The survival and safety of metastatic hepatocellular carcinoma treated with lenalidomide as second-line therapy: a case report and review of the literature

A rare case of intragastric Metastasis After Liver Transplantation for Liver Cancer

Robotic versus laparoscopic pancreaticoduodenectomy for pancreatic and periampullary tumors: a meta-analysis

Adjuvant sorafenib for hepatocellular carcinoma after radiofrequency ablation versus radiofrequency ablation: analysis of its efficacy and safety Author Information

Progress and perspectives on BMP9-ID1 activation of HIF-1α and VEGFA to promote angiogenesis in hepatic alveolar echinococcosis

The assessment of postoperative cholangitis in malignant biliary obstruction: a real-world study of nasobiliary drainage after endoscopic placement of self-expandable metal stent

Rhus verniciflua stokes extract, a traditional herbal medicine, combined with first-line chemotherapy for unresectable locally advanced and metastatic pancreatic cancer: a prospective observational pilot study

Prolonged survival by combination treatment of a standardized herbal extract from Japanese Kampo-Medicine (Juzentaihoto) and Gemcitabine in an orthotopic transplantation pancreatic cancer model

Sorafenib Combined with Tarexib for First-Line Treatment of Unresectable Hepatocellular Carcinoma and Its Predictive Role and Correlation with PD-L1 CTCs

Unveiling Tim-3 immune checkpoint expression in hepatocellular carcinoma through abdominal contrast-enhanced CT habitat radiomics

Deep learning radiomics based on contrast enhanced MRI for preoperatively predicting early recurrence in hepatocellular carcinoma after curative resection

Emerging horizons on molecular and circulating biomarkers in pancreatic adenocarcinoma